AzTrials
AzTrials

GaitNCT03886805

The Dual-task Training Under Different Priority Instructions on Gait Speed in Community-dwelling Older Adults

A study testing Dual task with variable- and fixed-priority instructions and Dual-task with variable-priority instructions in people with Gait and Postural Balance, run by University of Pernambuco at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study analyzed the effect of different modalities of dual-task training in the improvement of gait biomechanics, postural balance, falls episodes, executive functioning, and quality of life in community-dwelling older adults. Read more about this study

Who is it for?
Ages 60 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Gait, Postural Balance
What is being tested?
Dual task with variable- and fixed-priority instructions and Dual-task with variable-priority instructions
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteBrazil
Study dates
30 Apr 2019to 5 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Participants of both sexes
  • Age between 60 and 80 years old
  • Participants with a score greater or equal to 52 (up to a maximum of 56) in the Berg Balance Scale
  • Participants with a score greater or equal to 24 (up to a maximum of 30) in the Mini-mental State Exam
  • Participants who are able to walk uninterruptedly for a distance of 10-meter at a self-selected velocity of at least 1.0 m/s without the need from another person, cane or walker

Who cannot join

  • Self-report of two or more falls in the last 12 months
  • Any contraindication to balance postural training
  • Any contraindication to cognitive exercise training
  • With self-report of two or more falls in the last 12 months
  • Who is participating or have participated, in the last 6 months, in any regular and structured physical exercise program, for 3 or more times per week
  • Any chronic health condition, including cardiovascular disease, respiratory disease, stroke, active cancer, neurological or neuromuscular conditions whose exercise is contraindicated
Show all 11Show fewer
  • Any upper or lower limb fracture in the last 6 months
  • Evidence of any surgical procedures in the knees, ankles, and hips or muscle damage in the last 6 months
  • Uncontrolled diabetes.
  • No able to speak and understand the Portuguese language
  • Refusal to give informed consent

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Francis Trombini de Souza

    Petrolina, Pernambucano, 56302685

Other trials in Brazil

About this study

Official title: The Effectiveness of Dual-task Training With Variable- and Fixed-priority Instructions on Gait Speed in Community-dwelling Older Adults

This study analyzed the effect of different modalities of dual-task training in the improvement of gait biomechanics, postural balance, falls episodes, executive functioning, and quality of life in community-dwelling older adults. Half of the participants have undertaken a dual-task protocol training with progression from variable-priority to fixed-priority instructions, while the other half have undertaken a dual-task protocol training under variable-priority instructions.

Read the detailed description

Although dual-task training for improving postural balance is an emerging interest area, the effects of dual tasks and dual-task training on static and dynamic postural stability remain unclear. Even though variable (alternating) instructional priority dual-task training has been shown higher effect than fixed (concurrent) priority dual-task training approach to improving the balance impairments, we must consider in everyday pragmatic situations, motor, and cognitive tasks are often demanded simultaneously and this requires an individual's attention toward an external source of attention while performing a primary task. Then, our rationale for this study is older adults who underwent a training protocol composed of a dual task with variable and fixed instructional priority will achieve better improvements regarding the studied variables in comparison to the group who will be submitted a protocol composed only by dual-task with variable priority training. Therefore, this protocol for a six-month, double-blind, randomized controlled trial with six-month follow-up post-training analyzed whether examine whether a dual-task protocol training with progression from variable priority to fixed priority instructions is effective in improvement of gait biomechanics, postural balance, falls episodes, executive functioning and quality of life in community-dwelling older adults.

Being tested
Dual task with variable- and fixed-priority instructions, Dual-task with variable-priority instructions

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dual task with variable- and fixed-priority instructionsOther

    The participants were asked to perform dual-task activities focused, interchangeable or simultaneously, on balance (motor tasks) and on cognitive tasks performance, according to the instructional priority established by the physical therapist.

  • Dual-task with variable-priority instructionsOther

    The participants were asked to spend half the session focused on balance (motor tasks) and half the session focused on cognitive tasks performance, according to the instructional priority established by the physical therapist.

Study groups in NCT03886805
Study groupRoleWhat they receive
Dual task with variable- and fixed-priority instructionsExperimentalSixty-minute training sessions, 2 times a week for 24 weeks. From the 1st to 12th week the participants were trained under variable-priority instructions (half the session was focused on balance motor task and half the session focused on cognitive task performance). From the 13th to 24th week) the participants performed dual tasks under fixed-priority instructions (simultaneous focus attention on balance and cognitive tasks). The motor tasks were performed in a circuit composed of hula hoops, ropes (in a straight line and zigzag), agility ladder, traffic cones, steps, cardboard box, and other obstacles arranged on the floor (stable surface) or on mattresses (unstable surface), depending on the aiming of each training stage. The cognitive tasks will include activities such as saying fruits, animals, cities, and/or person names started with a specific letter, solving mathematical accounts, singing songs, reciting verses, working memory, among other cognitive tasks.
Receives: Other: Dual task with variable- and fixed-priority instructions
Dual-task with variable-priority instructionsActive comparatorSixty-minute training sessions, 2 times a week for 24 weeks (48 sessions). From the 1st to 24th week, the participants were trained under variable-priority instructions, in which they were asked to spend half the session focused on balance (motor task) and half the session focused on cognitive task performance. The motor tasks (gait and postural balance) of this protocol were performed in a circuit composed of hula hoops, ropes (in a straight line and zigzag), agility ladder, traffic cones, steps, cardboard box, and other obstacles arranged on the floor (stable surface) or on mattresses (unstable surface), depending on the aiming of each training stage. The cognitive tasks included activities such as saying fruits, animals, cities, and/or person names started with a specific letter, solving mathematical accounts, singing songs, reciting verses, rescue working memory, among other cognitive tasks.
Receives: Other: Dual-task with variable-priority instructions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gait spatiotemporal variables

    These variables will be acquired by a couple of inertial sensors attached on participant's feet during walking on a 30-meter flat and level corridor under a single-task (only gait), dual-task under variable- (gait alternating with a cognitive task) and fixed-priority (gait and cognitive task performing simultaneously).

    Measured: Post-randomization at week 12

  2. Gait spatiotemporal variables

    These variables will be acquired by a couple of inertial sensors attached on participant's feet during walking on a 30-meter flat and level corridor under a single-task (only gait), dual-task under variable- (gait alternating with a cognitive task) and fixed-priority (gait and cognitive task performing simultaneously).

    Measured: Post-randomization at week 24

  3. Gait spatiotemporal variables

    These variables will be acquired by a couple of inertial sensors attached on participant's feet during walking on a 30-meter flat and level corridor under a single-task (only gait), dual-task under variable- (gait alternating with a cognitive task) and fixed-priority (gait and cognitive task performing simultaneously).

    Measured: Post-intervention at week 12

  4. Gait spatiotemporal variables

    These variables will be acquired by a couple of inertial sensors attached on participant's feet during walking on a 30-meter flat and level corridor under a single-task (only gait), dual-task under variable- (gait alternating with a cognitive task) and fixed-priority (gait and cognitive task performing simultaneously).

    Measured: Post-intervention at week 24

Secondary outcomes (104)
  1. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during gait under single task

    These biomechanical variable acquired during gait under single task will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-randomization at week 12

  2. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during gait under single task

    These biomechanical variable acquired during gait under single task will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-radomization at week 24

  3. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during gait under single task

    These biomechanical variable acquired during gait under single task will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-intervention at week 12

  4. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during gait under single task

    These biomechanical variable acquired during gait under single task will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-intervention at week 24

  5. Tri-axial acceleration, angular velocity and displacement of the body center of mass during gait under dual-task with variable-priority instruction

    These biomechanical variable acquired during gait under dual-task with variable-priority instruction will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-randomization at week 12

  6. Tri-axial acceleration, angular velocity and displacement of the body center of mass during gait under dual-task with variable-priority instruction

    These biomechanical variable acquired during gait under dual-task with variable-priority instruction will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-randomization at week 24

  7. Tri-axial acceleration, angular velocity and displacement of the body center of mass during gait under dual-task with variable-priority instruction

    These biomechanical variable acquired during gait under dual-task with variable-priority instruction will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-intervention at week 12

  8. Tri-axial acceleration, angular velocity and displacement of the body center of mass during gait under dual-task with variable-priority instruction

    These biomechanical variable acquired during gait under dual-task with variable-priority instruction will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-intervention at week 24

  9. Tri-axial acceleration, angular velocity and displacement of the body center of mass during gait under dual-task with fixed-priority instruction

    These biomechanical variable acquired during gait under dual-task with fixed-priority instruction will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-randomization at week 12

  10. Tri-axial acceleration, angular velocity and displacement of the body center of mass during gait under dual-task with fixed-priority instruction

    These biomechanical variable acquired during gait under dual-task with fixed-priority instruction will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-randomization at week 24

  11. Tri-axial acceleration, angular velocity and displacement of the body center of mass during gait under dual-task with fixed-priority instruction

    These biomechanical variable acquired during gait under dual-task with fixed-priority instruction will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-intervention at week 12

  12. Tri-axial acceleration, angular velocity and displacement of the body center of mass during gait under dual-task with fixed-priority instruction

    These biomechanical variable acquired during gait under dual-task with fixed-priority instruction will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-intervention at week 24

  13. Tri-axial acceleration, angular velocity and displacement of the body center of mass during conventional timed up and go test.

    These biomechanical variable acquired during conventional timed up and go test will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-randomization at week 12

  14. Tri-axial acceleration, angular velocity and displacement of the body center of mass during conventional timed up and go test.

    These biomechanical variable acquired during conventional timed up and go test will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-randomization at week 24

  15. Tri-axial acceleration, angular velocity and displacement of the body center of mass during conventional timed up and go test.

    These biomechanical variable acquired during conventional timed up and go test will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-intervention at week 12

  16. Tri-axial acceleration, angular velocity and displacement of the body center of mass during conventional timed up and go test.

    These biomechanical variable acquired during conventional timed up and go test will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-intervention at week 24

  17. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during manual timed up and go test.

    These biomechanical variable acquired during manual timed up and go test will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-randomization at week 12

  18. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during manual timed up and go test.

    These biomechanical variable acquired during manual timed up and go test will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-randomization at week 24

  19. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during manual timed up and go test.

    These biomechanical variable acquired during manual timed up and go test will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-intervention at week 12

  20. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during manual timed up and go test.

    These biomechanical variable acquired during manual timed up and go test will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-intervention at week 24

  21. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during cognitive timed up and go test.

    These biomechanical variable acquired during cognitive timed up and go test will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-randomization at week 12

  22. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during cognitive timed up and go test.

    These biomechanical variable acquired during cognitive timed up and go test will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-randomization at week 24

  23. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during cognitive timed up and go test.

    These biomechanical variable acquired during cognitive timed up and go test will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-intervention at week 12

  24. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during cognitive timed up and go test.

    These biomechanical variable acquired during cognitive timed up and go test will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-intervention at week 24

  25. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during performing the Stroop test in quasi-static standing posture

    These biomechanical variable acquired during performing the Stroop test in quasi-static standing posture will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-randomization at week 12

  26. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during performing the Stroop test in quasi-static standing posture

    These biomechanical variable acquired during performing the Stroop test in quasi-static standing posture will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-randomization at week 24

  27. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during performing the Stroop test in quasi-static standing posture

    These biomechanical variable acquired during performing the Stroop test in quasi-static standing posture will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-intervention at week 12

  28. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during performing the Stroop test in quasi-static standing posture

    These biomechanical variable acquired during performing the Stroop test in quasi-static standing posture will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-intervention at week 24

  29. Tri-axial acceleration, angular velocity and displacement of the body center of mass during performing the Clinical Test of Sensory Interaction and Balance (CTSIB).

    These biomechanical variable acquired during performing the Clinical Test of Sensory Interaction and Balance (CTSIB) will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-randomization at week 12

  30. Tri-axial acceleration, angular velocity and displacement of the body center of mass during performing the Clinical Test of Sensory Interaction and Balance (CTSIB).

    These biomechanical variable acquired during performing the Clinical Test of Sensory Interaction and Balance (CTSIB) will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-randomization at week 24

  31. Tri-axial acceleration, angular velocity and displacement of the body center of mass during performing the Clinical Test of Sensory Interaction and Balance (CTSIB).

    These biomechanical variable acquired during performing the Clinical Test of Sensory Interaction and Balance (CTSIB) will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-intervention at week 12

  32. Tri-axial acceleration, angular velocity and displacement of the body center of mass during performing the Clinical Test of Sensory Interaction and Balance (CTSIB).

    These biomechanical variable acquired during performing the Clinical Test of Sensory Interaction and Balance (CTSIB) will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-intervention at week 24

  33. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during performing the Anterior Functional Reach test.

    These biomechanical variable acquired during performing the Anterior Functional Reach test will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-randomization at week 12

  34. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during performing the Anterior Functional Reach test.

    These biomechanical variable acquired during performing the Anterior Functional Reach test will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-randomization at week 24

  35. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during performing the Anterior Functional Reach test.

    These biomechanical variable acquired during performing the Anterior Functional Reach test will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-intervention at week 12

  36. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during performing the Anterior Functional Reach test.

    These biomechanical variable acquired during performing the Anterior Functional Reach test will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-intervention at week 24

  37. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during performing the Five Times Sit-to-stand test from a chair.

    These biomechanical variable acquired during performing the Five Times Sit-to-stand test from a chair will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-randomization at week 12

  38. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during performing the Five Times Sit-to-stand test from a chair.

    These biomechanical variable acquired during performing the Five Times Sit-to-stand test from a chair will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-randomization at week 24

  39. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during performing the Five Times Sit-to-stand test from a chair.

    These biomechanical variable acquired during performing the Five Times Sit-to-stand test from a chair will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-intervention at week 12

  40. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during performing the Five Times Sit-to-stand test from a chair.

    These biomechanical variable acquired during performing the Five Times Sit-to-stand test from a chair will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-intervention at week 24

  41. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during performing the Sitting-rising test from the floor.

    These biomechanical variable acquired during performing the Sitting-rising test from the floor will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-randomization at week 12

  42. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during performing the Sitting-rising test from the floor.

    These biomechanical variable acquired during performing the Sitting-rising test from the floor will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-randomization at week 24

  43. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during performing the Sitting-rising test from the floor.

    These biomechanical variable acquired during performing the Sitting-rising test from the floor will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-intervention at week 12

  44. Tri-axial acceleration, angular velocity, and displacement of the body center of mass during performing the Sitting-rising test from the floor.

    These biomechanical variable acquired during performing the Sitting-rising test from the floor will be assessed by an inertial sensor fixed on the participant's waist.

    Measured: Post-intervention at week 24

  45. Timed Up and Go conventional (TUG conventional)

    Test of basic mobility skills analyzed during rising from a chair, walking, turning the obstacle, and sitting again on the chair.

    Measured: Post-randomization at week 12

  46. Timed Up and Go conventional (TUG conventional)

    Test of basic mobility skills analyzed during rising from a chair, walking, turning the obstacle, and sitting again on the chair.

    Measured: Post-randomization at week 24

  47. Timed Up and Go conventional (TUG conventional)

    Test of basic mobility skills analyzed during rising from a chair, walking, turning the obstacle, and sitting again on the chair.

    Measured: Post-intervention at week 12

  48. Timed Up and Go conventional (TUG conventional)

    Test of basic mobility skills analyzed during rising from a chair, walking, turning the obstacle, and sitting again on the chair.

    Measured: Post-intervention at week 24

  49. Timed Up and Go manual (TUG manual)

    Test of basic mobility skills analyzed during rising from a chair, walking, turning the obstacle, and sitting again on the chair, while the participant carries a dish with a cup on it.

    Measured: Post-randomization at week 12

  50. Timed Up and Go manual (TUG manual)

    Test of basic mobility skills analyzed during rising from a chair, walking, turning the obstacle, and sitting again on the chair, while the participant carries a dish with a cup on it.

    Measured: Post-randomization at week 24

  51. Timed Up and Go manual (TUG manual)

    Test of basic mobility skills analyzed during rising from a chair, walking, turning the obstacle, and sitting again on the chair, while the participant carries a dish with a cup on it.

    Measured: Post-intervention at week 12

  52. Timed Up and Go manual (TUG manual)

    Test of basic mobility skills analyzed during rising from a chair, walking, turning the obstacle, and sitting again on the chair, while the participant carries a dish with a cup on it.

    Measured: Post-intervention at week 24

  53. Timed Up and Go cognitive (TUG cognitive)

    Test the basic mobility skills analyzed during raising from a chair, walking, bypassing the obstacle, and sitting back in the chair while the participant performs a concurrent cognitive task (solving mathematical subtraction operations).

    Measured: Post-randomization at week 12

  54. Timed Up and Go cognitive (TUG cognitive)

    Test the basic mobility skills analyzed during raising from a chair, walking, bypassing the obstacle, and sitting back in the chair while the participant performs a concurrent cognitive task (solving mathematical subtraction operations).

    Measured: Post-randomization at week 24

  55. Timed Up and Go cognitive (TUG cognitive)

    Test the basic mobility skills analyzed during raising from a chair, walking, bypassing the obstacle, and sitting back in the chair while the participant performs a concurrent cognitive task (solving mathematical subtraction operations).

    Measured: Post-intervention at week 12

  56. Timed Up and Go cognitive (TUG cognitive)

    Test the basic mobility skills analyzed during raising from a chair, walking, bypassing the obstacle, and sitting back in the chair while the participant performs a concurrent cognitive task (solving mathematical subtraction operations).

    Measured: Post-intervention at week 24

  57. Postural Balance Test (PBT)

    The Postural Balance Test evaluate the static and dynamic balance, in order to verify the typology of motor regulation, i.e. the exteroceptive or visual (six items) and interoceptive or vestibular (eight items), besides the general - proprioceptive information - of the movements.

    Measured: Post-randomization at week 12

  58. Postural Balance Test (PBT)

    The Postural Balance Test evaluate the static and dynamic balance, in order to verify the typology of motor regulation, i.e. the exteroceptive or visual (six items) and interoceptive or vestibular (eight items), besides the general - proprioceptive information - of the movements.

    Measured: Post-randomization at week 24

  59. Postural Balance Test (PBT)

    The Postural Balance Test evaluate the static and dynamic balance, in order to verify the typology of motor regulation, i.e. the exteroceptive or visual (six items) and interoceptive or vestibular (eight items), besides the general - proprioceptive information - of the movements.

    Measured: Post-intervention at week 12

  60. Postural Balance Test (PBT)

    The Postural Balance Test evaluate the static and dynamic balance, in order to verify the typology of motor regulation, i.e. the exteroceptive or visual (six items) and interoceptive or vestibular (eight items), besides the general - proprioceptive information - of the movements.

    Measured: Post-intervention at week 24

  61. Clinical Test of Sensory Interaction and Balance (CTSIB)

    This test will be used to assess the sensory integration on postural balance during standing on a stable and unstable surface with eyes open and closed.

    Measured: Post-randomization at week 12

  62. Clinical Test of Sensory Interaction and Balance (CTSIB)

    This test will be used to assess the sensory integration on postural balance during standing on a stable and unstable surface with eyes open and closed.

    Measured: Post-randomization at week 24

  63. Clinical Test of Sensory Interaction and Balance (CTSIB)

    This test will be used to assess the sensory integration on postural balance during standing on a stable and unstable surface with eyes open and closed.

    Measured: Post-intervention at week 12

  64. Clinical Test of Sensory Interaction and Balance (CTSIB)

    This test will be used to assess the sensory integration on postural balance during standing on a stable and unstable surface with eyes open and closed.

    Measured: Post-intervention at week 24

  65. Stroop test in sit posture

    This test will be used to measure a participant's selective attention capacity and skills, as well as his/her processing speed ability in sit posture

    Measured: Post-randomization at week 12

  66. Stroop test in sit posture

    This test will be used to measure a participant's selective attention capacity and skills, as well as his/her processing speed ability in sit posture

    Measured: Post-randomization at week 24

  67. Stroop test in sit posture

    This test will be used to measure a participant's selective attention capacity and skills, as well as his/her processing speed ability in sit posture

    Measured: Post-intervention at week 12

  68. Stroop test in a quasi-static standing posture

    This test will be used to measure a participant's selective attention capacity and skills, as well as his/her processing speed ability in quasi-static standing posture.

    Measured: Post-intervention at week 24

  69. Trail making test (TMT)

    Trail making test will be used to assess the participants executive abilities, which requires a variety of mental abilities including letter and number recognition mental flexibility, visual scanning, and motor function of upper limbs

    Measured: Post-randomization at week 12

  70. Trail making test (TMT)

    Trail making test will be used to assess the participants executive abilities, which requires a variety of mental abilities including letter and number recognition mental flexibility, visual scanning, and motor function of upper limbs

    Measured: Post-randomization at week 24

  71. Trail making test (TMT)

    Trail making test will be used to assess the participants executive abilities, which requires a variety of mental abilities including letter and number recognition mental flexibility, visual scanning, and motor function of upper limbs

    Measured: Post-intervention at week 12

  72. Trail making test (TMT)

    Trail making test will be used to assess the participants executive abilities, which requires a variety of mental abilities including letter and number recognition mental flexibility, visual scanning, and motor function of upper limbs

    Measured: Post-intervention at week 24

  73. Five Times Sit-to-Stand test from a chair

    The functional performance of the lower limbs taken to lifting and sitting on a chair for five times. The time will be measured by a stopwatch

    Measured: Post-randomization at week 12

  74. Five Times Sit-to-Stand test from a chair

    The functional performance of the lower limbs taken to lifting and sitting on a chair for five times. The time will be measured by a stopwatch

    Measured: Post-randomization at week 24

  75. Five Times Sit-to-Stand test from a chair

    The functional performance of the lower limbs taken to lifting and sitting on a chair for five times. The time will be measured by a stopwatch

    Measured: Post-intervention at week 12

  76. Five Times Sit-to-Stand test from a chair

    The functional performance of the lower limbs taken to lifting and sitting on a chair for five times. The time will be measured by a stopwatch

    Measured: Post-intervention at week 24

  77. Sitting-and-rising test from the floor

    Sitting-and-rising test from the floor will be used to quantify how many supports (hands and/or knees or, still, hands on the knees or legs) the individual uses to sit and lift from the floor.

    Measured: Post-randomization at week 12

  78. Sitting-and-rising test from the floor

    Sitting-and-rising test from the floor will be used to quantify how many supports (hands and/or knees or, still, hands on the knees or legs) the individual uses to sit and lift from the floor.

    Measured: Post-randomization at week 24

  79. Sitting-and-rising test from the floor

    Sitting-and-rising test from the floor will be used to quantify how many supports (hands and/or knees or, still, hands on the knees or legs) the individual uses to sit and lift from the floor.

    Measured: Post-intervention at week 12

  80. Sitting-and-rising test from the floor

    Sitting-and-rising test from the floor will be used to quantify how many supports (hands and/or knees or, still, hands on the knees or legs) the individual uses to sit and lift from the floor.

    Measured: Post-intervention at week 24

  81. Anterior functional reach test

    Anterior functional reach test will be used to determine how far the participants are able to move forward within their stability limit. It is widely used to identify the risk of falling in older adults

    Measured: Post-randomization at week 12

  82. Anterior functional reach test

    Anterior functional reach test will be used to determine how far the participants are able to move forward within their stability limit. It is widely used to identify the risk of falling in older adults

    Measured: Post-randomization at week 24

  83. Anterior functional reach test

    Anterior functional reach test will be used to determine how far the participants are able to move forward within their stability limit. It is widely used to identify the risk of falling in older adults

    Measured: Post-intervention at week 12

  84. Anterior functional reach test

    Anterior functional reach test will be used to determine how far the participants are able to move forward within their stability limit. It is widely used to identify the risk of falling in older adults

    Measured: Post-intervention at week 24

  85. Falls Efficacy Scale-International (FES-I)

    The 16-item Falls Efficacy Scale-International will be used to measure the participant's fear of falling (the concerns about falling). The sum of all 16 items is considered to compute a total score. The higher the total score achieved by the participant, the higher the concerns about falling.

    Measured: Post-randomization at week 12

  86. Falls Efficacy Scale-International (FES-I)

    The 16-item Falls Efficacy Scale-International will be used to measure the participant's fear of falling (the concerns about falling). The sum of all 16 items is considered to compute a total score. The higher the total score achieved by the participant, the higher the concerns about falling.

    Measured: Post-randomization at week 24

  87. Falls Efficacy Scale-International (FES-I)

    The 16-item Falls Efficacy Scale-International will be used to measure the participant's fear of falling (the concerns about falling). The sum of all 16 items is considered to compute a total score. The higher the total score achieved by the participant, the higher the concerns about falling.

    Measured: Post-intervention at week 12

  88. Falls Efficacy Scale-International (FES-I)

    The 16-item Falls Efficacy Scale-International will be used to measure the participant's fear of falling (the concerns about falling). The sum of all 16 items is considered to compute a total score. The higher the total score achieved by the participant, the higher the concerns about falling.

    Measured: Post-intervention at week 24

  89. Activities-specific Balance Confidence (ABC Scale)

    The 16-item Activities-specific Balance Confidence Scale will be used to measure the level of balance confidence of the individual during the accomplishment in performing daily activities. The higher the total score achieved by the participant, the higher the level of balance confidence and functioning in daily activities

    Measured: Post-randomization at week 12

  90. Activities-specific Balance Confidence (ABC Scale)

    The 16-item Activities-specific Balance Confidence Scale will be used to measure the level of balance confidence of the individual during the accomplishment in performing daily activities. The higher the total score achieved by the participant, the higher the level of balance confidence and functioning in daily activities

    Measured: Post-randomization at week 24

  91. Activities-specific Balance Confidence (ABC Scale)

    The 16-item Activities-specific Balance Confidence Scale will be used to measure the level of balance confidence of the individual during the accomplishment in performing daily activities. The higher the total score achieved by the participant, the higher the level of balance confidence and functioning in daily activities

    Measured: Post-intervention at week 12

  92. Activities-specific Balance Confidence (ABC Scale)

    The 16-item Activities-specific Balance Confidence Scale will be used to measure the level of balance confidence of the individual during the accomplishment in performing daily activities. The higher the total score achieved by the participant, the higher the level of balance confidence and functioning in daily activities

    Measured: Post-intervention at week 24

  93. Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36)

    Medical Outcomes Study 36-Item Short-Form Health Survey will be used to evaluate the quality of life of the participants. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability

    Measured: Post-randomization at week 12

  94. Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36)

    Medical Outcomes Study 36-Item Short-Form Health Survey will be used to evaluate the quality of life of the participants. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability

    Measured: Post-randomization at week 24

  95. Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36)

    Medical Outcomes Study 36-Item Short-Form Health Survey will be used to evaluate the quality of life of the participants. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability

    Measured: Post-intervention at week 12

  96. Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36)

    Medical Outcomes Study 36-Item Short-Form Health Survey will be used to evaluate the quality of life of the participants. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability

    Measured: Post-intervention at week 24

  97. Short form of the Geriatric Depression Scale (GDS-15)

    This 15-item instrument will be used to evaluate the suggestive depression symptoms in the participants. Its items require a yes/no response. Answers indicating depression are in bold and italicized; score one point for each one selected. Each answer "yes" marked with X in questions 3, 4, 6, 8, 9, 10, 12, 14 and 15 or answer "no" noted in questions 1, 5, 7, 11 and 13, computes 1 point. A score of 0 to 5 is normal. A score greater than 5 indicates depression

    Measured: Post-randomization at week 12

  98. Short form of the Geriatric Depression Scale (GDS-15)

    This 15-item instrument will be used to evaluate the suggestive depression symptoms in the participants. Its items require a yes/no response. Answers indicating depression are in bold and italicized; score one point for each one selected. Each answer "yes" marked with X in questions 3, 4, 6, 8, 9, 10, 12, 14 and 15 or answer "no" noted in questions 1, 5, 7, 11 and 13, computes 1 point. A score of 0 to 5 is normal. A score greater than 5 indicates depression

    Measured: Post-randomization at week 24

  99. Short form of the Geriatric Depression Scale (GDS-15)

    This 15-item instrument will be used to evaluate the suggestive depression symptoms in the participants. Its items require a yes/no response. Answers indicating depression are in bold and italicized; score one point for each one selected. Each answer "yes" marked with X in questions 3, 4, 6, 8, 9, 10, 12, 14 and 15 or answer "no" noted in questions 1, 5, 7, 11 and 13, computes 1 point. A score of 0 to 5 is normal. A score greater than 5 indicates depression

    Measured: Post-intervention at week 12

  100. Short form of the Geriatric Depression Scale (GDS-15)

    This 15-item instrument will be used to evaluate the suggestive depression symptoms in the participants. Its items require a yes/no response. Answers indicating depression are in bold and italicized; score one point for each one selected. Each answer "yes" marked with X in questions 3, 4, 6, 8, 9, 10, 12, 14 and 15 or answer "no" noted in questions 1, 5, 7, 11 and 13, computes 1 point. A score of 0 to 5 is normal. A score greater than 5 indicates depression

    Measured: Post-intervention at week 24

  101. The falls events

    Fall events will be evaluated through a falls diary, delivered monthly by each participant. The participants should note in this diary the day and the fall causes and circumstances.

    Measured: Post-randomization at week 12

  102. The falls events

    Fall events will be evaluated through a falls diary, delivered monthly by each participant. The participants should note in this diary the day and the fall causes and circumstances.

    Measured: Post-randomization at week 24

  103. The falls events

    Fall events will be evaluated through a falls diary, delivered monthly by each participant. The participants should note in this diary the day and the fall causes and circumstances.

    Measured: Post-intervention at week 12

  104. The falls events

    Fall events will be evaluated through a falls diary, delivered monthly by each participant. The participants should note in this diary the day and the fall causes and circumstances.

    Measured: Post-intervention at week 24

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Mar 2019
  2. Study start30 Apr 2019
  3. Primary completion5 Mar 2020
  4. Study completion5 Mar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03886805
Sponsor's protocol ID
U1111-1229-1346
Status last verified
Jul 2021
First submitted
12 Mar 2019
Last updated
21 Jul 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Trombini-Souza F, de Maio Nascimento M, da Silva TFA, de Araujo RC, Perracini MR, Sacco ICN. Dual-task training with progression from variable- to fixed-priority instructions versus dual-task training with variable-priority on gait speed in community-dwelling older adults: A protocol for a randomized controlled trial : Variable- and fixed-priority dual-task for older adults. BMC Geriatr. 2020 Feb 22;20(1):76. doi: 10.1186/s12877-020-1479-2.

    PubMed 32087694

Questions about this trial

What is this clinical trial studying?

A study testing Dual task with variable- and fixed-priority instructions and Dual-task with variable-priority instructions in people with Gait and Postural Balance, run by University of Pernambuco at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gait spatiotemporal variables (time frame: Post-randomization at week 12). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03886805, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2021; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in